The Spin
Narrative A
The results of this trial give hope to countless people suffering from head and neck cancers. As the study has made crystal clear, amivantamab is an effective drug for treating these ailments. With the high levels of recorded improvement in patients, the further research and development of this drug could provide a groundbreaking treatment option in the future.
Narrative B
While the results of Johnson & Johnson’s trial are promising, it must be remembered that amivantamab is a toxic drug, with a whole host of adverse side effects. These can include anything from rashes to thromboembolism, when treated in combination with lazertinib. Doctors, therefore, must take care in ensuring the safest possible application of this drug.
Metaculus Prediction
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.17.0